As for LC3 expression, the heterogeneity due to the mix of colon and rectal cancers as well as the variation in the stage from stage I to IV complicates the interpretation of the prognostic value of BECN1 expression in colorectal cancers [24]. This evidence concerns the gene BECN1 and rectal cancer.